Plasma 17α-Hydroxyprogesterone in Spironolactone-Treated Hypertensives

Abstract
When measured by a specific radioassay method which excludes drug interference, plasma 17.alpha.-hydroxyprogesterone levels were similar in spironolactone treated hypertensives, in untreated hypertensives and in normotensive volunteers. No in vivo evidence for a significant inhibitory effect of spironolactone on adrenal 11.beta., 17.alpha. and 21 hydroxylases was uncovered.

This publication has 0 references indexed in Scilit: